8-KEarnings & ResultsExhibits & Filings

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Apr 29, 2021)

Filed April 29, 2021For Securities:GILD

Summary

Gilead Sciences, Inc. (GILD) announced its financial results for the first quarter ended March 31, 2021, via a press release filed on April 29, 2021. The report highlights the company's operational performance and financial condition during the period. Gilead provided both GAAP and non-GAAP financial information, emphasizing that the non-GAAP measures are intended to supplement understanding and are used internally for operational and planning purposes. Investors are advised to review the reconciliation tables provided in the press release for a comprehensive view of these adjustments. The primary purpose of this 8-K filing is to furnish the press release containing the quarterly results. While the filing itself does not contain detailed financial statements, it directs investors to Exhibit 99.1, the earnings press release, for the complete breakdown of financial performance. This includes specific revenue figures, earnings per share, and any other relevant financial metrics that management believes are important for assessing the company's performance.

Key Highlights

  • 1Gilead Sciences reported its first-quarter 2021 financial results on April 29, 2021.
  • 2The company provided both GAAP and non-GAAP financial information to investors.
  • 3Non-GAAP financial measures are presented as supplementary information and used internally by management.
  • 4A reconciliation between GAAP and non-GAAP financial information is available in the filed press release (Exhibit 99.1).
  • 5The 8-K filing serves to officially submit the earnings press release as an exhibit.
  • 6Information furnished in this 8-K is not considered 'filed' for the purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings.

Frequently Asked Questions

The detailed financial results for the first quarter of 2021 are available in the press release issued by Gilead Sciences on April 29, 2021, which is included as Exhibit 99.1 to this 8-K filing.

Gilead presents both GAAP (Generally Accepted Accounting Principles) and non-GAAP financial measures. Management believes non-GAAP information is useful for investors as it aids in understanding operational performance. Non-GAAP measures may exclude certain items and are calculated differently than under GAAP. A reconciliation to explain the differences is provided in the press release.

No, the information furnished in this Form 8-K, including the attached press release, is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it intended to be incorporated by reference into any other filing under the Securities Act of 1933 or the Exchange Act.